N-Hydroxy Vortioxetine | CAS 1393644-67-1 - Request Quote
N-Hydroxy Vortioxetine
| SZ CAT No: | SZ-V018096 |
| CAS No | 1393644-67-1 |
| Mol.F. | C18H22N2OS |
| Mol.Wt. |
314.4 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
N-Hydroxy Vortioxetine is chemically 4-(2-((2,4-dimethylphenyl)thio)phenyl)piperazin-1-ol. N-Hydroxy Vortioxetine is supplied with detailed characterization data compliant with regulatory guideline. N-Hydroxy Vortioxetine can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Vortioxetine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1393644-67-1
Purchase 1393644-67-1
Order 1393644-67-1
Enquire 1393644-67-1
price of 1393644-67-1
1393644-67-1 Supplier
1393644-67-1 Manufacturer
1393644-67-1 Exporter
buy high quality N-Hydroxy Vortioxetine
Purchase N-Hydroxy Vortioxetine
N-Hydroxy Vortioxetine suppliers
N-Hydroxy Vortioxetine manufacturers
N-Hydroxy Vortioxetine price
Order N-Hydroxy Vortioxetine
Enquire N-Hydroxy Vortioxetine
N-Hydroxy Vortioxetine cost
N-Hydroxy Vortioxetine Supplier
N-Hydroxy Vortioxetine Distributor
N-Hydroxy Vortioxetine for Method Validation
Vortioxetine Reference Standard
N-Hydroxy Vortioxetine for ANDA Filing
N-Hydroxy Vortioxetine for Forced Degradation Studies
N-Hydroxy Vortioxetine Identification Standards
N-Hydroxy Vortioxetine for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.